Infectopharm Expands into Poland with New Central European Hub

German pharmaceutical company Infectopharm is expanding into Poland, marking its fifth European sales and marketing hub. The new office will be led by Beata Treszczynska, an experienced executive with a background in multiple medical fields. The move comes as part of the company's broader growth strategy across the continent.

The Poland office will serve as a key market for Infectopharm, chosen for its large population, increasing healthcare investment, and central European location. Later this year, the company plans to launch its first products there, supported by a dedicated field sales team of six.

Beata Treszczynska, appointed as managing director, brings expertise in CNS disorders, dermatology, and clinical antibiotics. Her leadership will guide the new subsidiary as it establishes operations. Infectopharm's international business already spans over 30 countries, with existing subsidiaries in Austria, Italy, France, and the UK. The company employs more than 450 people and reported revenues of €300 million in 2024. By 2026, it aims to open additional sales and marketing offices in five more European countries.

The Polish expansion strengthens Infectopharm's presence in Central Europe. With a local team in place and products set to launch soon, the company expects the new hub to contribute to its continued growth. The move aligns with its long-term plan to expand across the continent.